Legal status · Canada
Is Everolimus legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Everolimus is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Everolimus in Canada at a glance
| Classification | Health Canada approved, prescription only |
|---|---|
| Health Canada approval status | Approved by Health Canada for its labeled use |
| Human studies cited | 3 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Everolimus profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Health Canada has approved Everolimus for at least one labeled indication, so a pharmaceutical-grade product exists in Canada and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Everolimus is
The rapamycin analogue that produced the first credible human geroscience result: improved influenza vaccine response in older adults in a randomised trial.
Everolimus matters to this site for a reason unrelated to its approved uses. It is an approved cancer and transplant drug, and it was also the molecule used for the first randomised trial that took the mTOR longevity hypothesis into humans and got a positive answer.
Mechanism: A rapamycin analogue, or rapalog, that binds FKBP12 and inhibits mechanistic target of rapamycin complex 1. mTORC1 is the central nutrient and growth-factor sensor: when it is active, cells build protein and suppress autophagy, and when it is inhibited, autophagy and stress resistance increase.
Regulatory history: FDA-approved as Afinitor for several cancers and as Zortress for prophylaxis of organ rejection. Not approved for any ageing or immune-ageing indication.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Everolimus at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Everolimus in other countries
Frequently asked questions
Is Everolimus legal in Canada?
Yes. Everolimus is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Can I buy Everolimus in Canada?
Only with a prescription. Everolimus is classified as "Health Canada approved, prescription only" in Canada, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Everolimus Health Canada approved?
Yes, for its labeled indication. In Canada Everolimus is classified as "Health Canada approved, prescription only". For comparison, the US FDA status is: FDA-approved as Afinitor for several cancers and as Zortress for prophylaxis of organ rejection. Not approved for any ageing or immune-ageing indication.. On the evidence, 3 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Everolimus live on its compound profile.
Everolimus profileThis page is general information about the regulatory status of Everolimus in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.